Skip to main content
. Author manuscript; available in PMC: 2013 Aug 20.
Published in final edited form as: Menopause. 2011 Sep;18(9):943–950. doi: 10.1097/gme.0b013e3182113672

Table 3.

Hormone Therapy Use and Angiographic Coronary Artery Disease

No Coronary Disease (n=487) Coronary Disease (n=167) OR (95% CI) P
Overall:
History of HT use (%) 66 39 0.41 (0.28,0.60) <0.0001
Current HT use (%) 49 29 0.51 (0.34,0.75) 0.0007
Among Ever HT Users: (n=319) (n=65)
Age onset of HT (yrs±SD) 46±11 55±11 1.03 (1.00,1.06) 0.052
Duration of HT use (yrs±SD) 10.4±10.0 8.7±10.2 0.98 (0.95,1.003) 0.08
Among Current HT Users: (n=241) (n=48)
Unopposed estrogen (%) 74 75 1.03 (0.55,2.11) 0.93

Abbreviations and definitions as previously.

All ORs, CIs, and p values are age-adjusted.